National Health Investors (NYSE:NHI) Releases FY 2024 Earnings Guidance

National Health Investors (NYSE:NHI) updated its FY 2024 earnings guidance on Monday. The company provided EPS guidance of 4.370-4.430 for the period, compared to the consensus EPS estimate of 4.350. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on NHI shares. StockNews.com downgraded National Health Investors from a buy rating to a hold rating in a report on Thursday, April 18th. Wedbush upped their price objective on shares of National Health Investors from $64.00 to $66.00 and gave the company an outperform rating in a research report on Monday, March 18th. BMO Capital Markets raised shares of National Health Investors from a market perform rating to an outperform rating and set a $67.00 price target on the stock in a research report on Tuesday, March 12th. Truist Financial raised their target price on shares of National Health Investors from $55.00 to $58.00 and gave the stock a hold rating in a report on Thursday, April 4th. Finally, Wells Fargo & Company raised shares of National Health Investors from an equal weight rating to an overweight rating and increased their price objective for the stock from $55.00 to $63.00 in a report on Monday, February 26th. Five analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of Hold and a consensus target price of $60.50.

National Health Investors Price Performance

Shares of NYSE:NHI opened at $64.25 on Tuesday. National Health Investors has a 1-year low of $48.51 and a 1-year high of $65.23. The firm has a market capitalization of $2.79 billion, a PE ratio of 20.53 and a beta of 0.95. The business’s 50 day moving average is $60.67 and its 200-day moving average is $56.36. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.90.

National Health Investors Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 3rd. Investors of record on Thursday, March 28th were paid a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 5.60%. The ex-dividend date of this dividend was Wednesday, March 27th. National Health Investors’s dividend payout ratio is 115.02%.

Insider Activity at National Health Investors

In other National Health Investors news, Director Charlotte A. Swafford acquired 10,000 shares of National Health Investors stock in a transaction on Tuesday, February 27th. The shares were bought at an average price of $58.69 per share, with a total value of $586,900.00. Following the completion of the purchase, the director now owns 110,185 shares in the company, valued at $6,466,757.65. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 8.21% of the stock is owned by insiders.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.